Tag: OBLN
Obalon Granted First US Patent for its Proprietary Intragastric Balloon System.
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the grant...
Companies Pioneering Novel Solutions to Tackle Obesity
Obesity and overweight together are the leading cause of preventable death in the U.S leading to a loss of 47 percent more life years...
We are looking for talented interns to learn and help investors find valuable companies.